Insider
Date
Role
Action
Shares
Price
Amount
Harmon Cyrus
24 Jul 2026
Director
Sell
12,500
$11.71
$146.43K
Harmon Cyrus
23 Jul 2026
Director
Sell
12,500
$11.58
$144.74K
Mitchell Shawnte
4 Mar 2026
CHIEF LEGAL OFFICER
Sold after exercise
233
$24.69
$5.75K
Mitchell Shawnte
4 Mar 2026
CHIEF LEGAL OFFICER
Sold after exercise
24,767
$24.25
$600.60K
Mitchell Shawnte
3 Mar 2026
CHIEF LEGAL OFFICER
Sold after exercise
15,000
$23.01
$345.15K
Harmon Cyrus
20 Jan 2026
Director
Sell
10,000
$26.88
$268.80K
Kovacs Shane William Charles
15 Jan 2026
CH. OPERATING & FINANCIAL OFF.
Sell
100,000
$28.73
$2.87M
Myles David C.
14 Jan 2026
CH. DISCOV. & NON-CLIN DEV OFF
Sold after exercise
35,003
$28.99
$1.01M
Myles David C.
14 Jan 2026
CH. DISCOV. & NON-CLIN DEV OFF
Sold after exercise
14,997
$28.60
$428.91K
Harmon Cyrus
14 Jan 2026
Director
Sell
3,489
$29.12
$101.60K
Myles David C.
13 Jan 2026
CH. DISCOV. & NON-CLIN DEV OFF
Sold after exercise
200
$28.49
$5.70K
Myles David C.
13 Jan 2026
CH. DISCOV. & NON-CLIN DEV OFF
Sold after exercise
49,800
$27.60
$1.37M
Kovacs Shane William Charles
13 Jan 2026
CH. OPERATING & FINANCIAL OFF.
Sell
3,822
$28.01
$107.05K
Myles David C.
12 Jan 2026
CH. DISCOV. & NON-CLIN DEV OFF
Sell
indirect
10,000
$28.34
$283.40K
Zojwalla Naseem
23 Dec 2025
Chief Medical Officer
Sold after exercise
99,509
$27.66
$2.75M
Zojwalla Naseem
22 Dec 2025
Chief Medical Officer
Sold after exercise
100,000
$28.04
$2.80M
Harmon Cyrus
22 Dec 2025
Director
Sell
2,881
$28.53
$82.19K
Zojwalla Naseem
19 Dec 2025
Chief Medical Officer
Sold after exercise
12,921
$28.93
$373.80K
Zojwalla Naseem
19 Dec 2025
Chief Medical Officer
Sold after exercise
57,079
$28.03
$1.60M
Myles David C.
19 Dec 2025
CH. DISCOV. & NON-CLIN DEV OFF
Sell
6,046
$31.39
$189.78K
Myles David C.
19 Dec 2025
CH. DISCOV. & NON-CLIN DEV OFF
Sell
43,729
$30.40
$1.33M
Myles David C.
19 Dec 2025
CH. DISCOV. & NON-CLIN DEV OFF
Sell
1,225
$28.08
$34.40K
CLARK IAN T
19 Dec 2025
Director
Sold after exercise
41,840
$30.48
$1.28M
CLARK IAN T
19 Dec 2025
Director
Sold after exercise
193,056
$29.71
$5.74M
CLARK IAN T
19 Dec 2025
Director
Sold after exercise
29,904
$28.83
$862.13K
RAPPAPORT ANDREW
21 Nov 2025
Director
Exercised, kept
35,868
$0.39
$13.99K
Harmon Cyrus
18 Sep 2025
Director
Sell
indirect
3,086
$8.32
$25.68K
Harmon Cyrus
18 Sep 2025
Director
Sell
10,000
$8.33
$83.30K
Harmon Cyrus
16 Sep 2025
Director
Sell
indirect
1,914
$8.08
$15.47K
Harmon Cyrus
16 Sep 2025
Director
Sell
10,000
$8.04
$80.40K
Bain Capital Life Sciences Investors, LLC
8 Jan 2025
10% owner
Buy
indirect
300,000
$5.76
$1.73M
Graham G. Walmsley
17 Dec 2024
Director
Buy
indirect
700,761
$6.75
$4.73M
Graham G. Walmsley
17 Dec 2024
Director
Sell
indirect
700,761
$6.75
$4.73M
Zojwalla Naseem
16 Dec 2024
CHIEF MEDICAL OFFICER
Exercised, kept
14,000
$4.87
$68.18K
Bohen Sean
11 Dec 2024
PRESIDENT AND CEO
Sell
1,267
$9.39
$11.90K
Bohen Sean
11 Dec 2024
PRESIDENT AND CEO
Sell
55,907
$8.66
$484.15K
Kovacs Shane William Charles
11 Dec 2024
CH. OPERATING & FINANCIAL OFF.
Sell
406
$9.39
$3.81K
Kovacs Shane William Charles
11 Dec 2024
CH. OPERATING & FINANCIAL OFF.
Sell
17,950
$8.66
$155.45K
Zojwalla Naseem
11 Dec 2024
CHIEF MEDICAL OFFICER
Sell
320
$9.39
$3.00K
Zojwalla Naseem
11 Dec 2024
CHIEF MEDICAL OFFICER
Sell
14,202
$8.66
$122.99K
Myles David C.
11 Dec 2024
CH. DISCOV. & NON-CLIN DEV OFF
Sell
300
$9.39
$2.82K
Myles David C.
11 Dec 2024
CH. DISCOV. & NON-CLIN DEV OFF
Sell
13,314
$8.66
$115.30K
Harmon Cyrus
11 Dec 2024
Director
Sell
179
$9.39
$1.68K
Harmon Cyrus
11 Dec 2024
Director
Sell
7,958
$8.66
$68.92K
Bohen Sean
10 Dec 2024
PRESIDENT AND CEO
Sell
52,328
$9.37
$490.31K
Kovacs Shane William Charles
10 Dec 2024
CH. OPERATING & FINANCIAL OFF.
Sell
16,803
$9.37
$157.44K
Zojwalla Naseem
10 Dec 2024
CHIEF MEDICAL OFFICER
Sell
13,283
$9.37
$124.46K
Myles David C.
10 Dec 2024
CH. DISCOV. & NON-CLIN DEV OFF
Sell
12,452
$9.38
$116.80K
Harmon Cyrus
10 Dec 2024
Director
Sell
8,256
$9.37
$77.36K
Kovacs Shane William Charles
15 Nov 2024
Ch. Operating & Financial Off.
Exercised, kept
25,000
$7.02
$175.50K
Paradigm Biocapital Advisors LP
1 Aug 2024
10% owner
Sell
indirect
529,501
$14.92
$7.90M
Paradigm Biocapital Advisors LP
1 Aug 2024
10% owner
Sell
indirect
1,870,499
$14.92
$27.90M
Harmon Cyrus
30 Jul 2024
Director
Sold on a plan
934
$15.55
$14.52K
Harmon Cyrus
29 Jul 2024
Director
Sold on a plan
4,066
$15.58
$63.35K
Harmon Cyrus
11 Jul 2024
Director
Sold on a plan
5,000
$12.26
$61.30K
Harmon Cyrus
28 Jun 2024
Director
Sold on a plan
20,000
$10.77
$215.40K
Harmon Cyrus
4 Jun 2024
Director
Sold on a plan
5,000
$12.33
$61.65K
Graham G. Walmsley
4 Jun 2024
Director
Sell
indirect
475,000
$14.85
$7.05M
Graham G. Walmsley
4 Jun 2024
Director
Sell
indirect
700,000
$14.85
$10.40M
Harmon Cyrus
3 Jun 2024
Director
Sold on a plan
5,000
$10.93
$54.65K
Harmon Cyrus
31 May 2024
Director
Sold on a plan
15,000
$9.41
$141.15K
Zojwalla Naseem
24 May 2024
CHIEF MEDICAL OFFICER
Exercised, kept
9,460
$4.87
$46.07K
Harmon Cyrus
6 May 2024
Director
Sold on a plan
5,000
$10.92
$54.60K
Harmon Cyrus
30 Apr 2024
Director
Sold on a plan
15,000
$9.51
$142.65K
Harmon Cyrus
28 Mar 2024
Director
Sold on a plan
20,000
$10.97
$219.40K
Zojwalla Naseem
18 Mar 2024
CHIEF MEDICAL OFFICER
Exercised, kept
13,700
$4.87
$66.72K
Harmon Cyrus
29 Feb 2024
Director
Sold on a plan
100
$13.00
$1.30K
Harmon Cyrus
29 Feb 2024
Director
Sold on a plan
24,900
$12.41
$309.01K
Harmon Cyrus
1 Feb 2024
Director
Sold on a plan
5,000
$15.56
$77.80K
Harmon Cyrus
31 Jan 2024
Director
Sold on a plan
25,000
$12.23
$305.75K
Zojwalla Naseem
25 Jan 2024
CHIEF MEDICAL OFFICER
Exercised, kept
20,000
$7.02
$140.40K
Kovacs Shane William Charles
12 Jan 2024
CH. OPERATING & FINANCIAL OFF.
Exercised, kept
50,000
$7.02
$351.00K
Harmon Cyrus
29 Dec 2023
Director
Sell
2,500
$14.10
$35.25K
Harmon Cyrus
29 Dec 2023
Director
Sell
22,500
$13.30
$299.25K
Kovacs Shane William Charles
12 Dec 2023
CH. OPERATING & FINANCIAL OFF.
Exercised, kept
10,000
$7.02
$70.20K
Zojwalla Naseem
11 Dec 2023
CHIEF MEDICAL OFFICER
Exercised, kept
2,900
$7.02
$20.36K
Zojwalla Naseem
6 Dec 2023
CHIEF MEDICAL OFFICER
Exercised, kept
13,100
$7.02
$91.96K
Paradigm Biocapital Advisors LP
6 Dec 2023
10% owner
Buy
indirect
100,000
$11.60
$1.16M
Graham G. Walmsley
5 Dec 2023
Director
Buy
indirect
50,000
$13.09
$654.25K
Graham G. Walmsley
5 Dec 2023
Director
Buy
indirect
50,000
$14.95
$747.48K
Graham G. Walmsley
5 Dec 2023
Director
Buy
indirect
31,870
$14.73
$469.55K
Harmon Cyrus
30 Nov 2023
Director
Sold on a plan
25,000
$12.57
$314.25K
Kovacs Shane William Charles
22 Nov 2023
CH. OPERATING & FINANCIAL OFF.
Sell
9,145
$13.89
$127.02K
Bohen Sean
22 Nov 2023
PRESIDENT AND CEO
Sell
27,932
$13.90
$388.25K
Myles David C.
22 Nov 2023
CH. DISCOV. & NON-CLIN DEV OFF
Sell
6,653
$13.89
$92.41K
Zojwalla Naseem
22 Nov 2023
CHIEF MEDICAL OFFICER
Sell
7,095
$13.89
$98.55K
Harmon Cyrus
22 Nov 2023
Director
Sell
3,989
$13.90
$55.45K
Kovacs Shane William Charles
21 Nov 2023
CH. OPERATING & FINANCIAL OFF.
Sell
700
$15.27
$10.69K
Kovacs Shane William Charles
21 Nov 2023
CH. OPERATING & FINANCIAL OFF.
Sell
8,897
$14.83
$131.94K
Bohen Sean
21 Nov 2023
PRESIDENT AND CEO
Sell
2,602
$15.29
$39.78K
Bohen Sean
21 Nov 2023
PRESIDENT AND CEO
Sell
26,691
$14.84
$396.09K
Myles David C.
21 Nov 2023
CH. DISCOV. & NON-CLIN DEV OFF
Sell
200
$15.32
$3.06K
Myles David C.
21 Nov 2023
CH. DISCOV. & NON-CLIN DEV OFF
Sell
6,776
$14.87
$100.76K
Zojwalla Naseem
21 Nov 2023
CHIEF MEDICAL OFFICER
Sell
200
$15.33
$3.07K
Zojwalla Naseem
21 Nov 2023
CHIEF MEDICAL OFFICER
Sell
7,261
$14.83
$107.68K
Harmon Cyrus
21 Nov 2023
Director
Sell
4,192
$14.86
$62.29K
Myles David C.
8 Nov 2023
CH. DISCOV. & NON-CLIN DEV OFF
Sold on a plan
200
$17.61
$3.52K
Myles David C.
3 Nov 2023
CH. DISCOV. & NON-CLIN DEV OFF
Sold on a plan
541
$17.51
$9.47K
Harmon Cyrus
2 Nov 2023
Director
Sold on a plan
5,000
$15.64
$78.20K
Myles David C.
2 Nov 2023
CH. DISCOV. & NON-CLIN DEV OFF
Sold on a plan
3,332
$15.36
$51.18K
Myles David C.
1 Nov 2023
CH. DISCOV. & NON-CLIN DEV OFF
Sold on a plan
6,668
$15.02
$100.15K
Harmon Cyrus
31 Oct 2023
Director
Sold on a plan
25,000
$12.05
$301.25K
Harmon Cyrus
29 Sep 2023
Director
Sold on a plan
25,000
$12.41
$310.25K
Myles David C.
19 Sep 2023
CH. DISCOV. & NON-CLIN DEV OFF
Sold on a plan
20,000
$12.67
$253.40K
BVF PARTNERS L P/IL
12 Sep 2023
Director
Buy
52,801
$9.84
$519.56K
BVF PARTNERS L P/IL
12 Sep 2023
Director
Buy
677,853
$9.84
$6.67M
BVF PARTNERS L P/IL
12 Sep 2023
Director
Buy
775,278
$9.84
$7.63M
Graham G. Walmsley
12 Sep 2023
Director
Buy
indirect
508,130
$9.84
$5.00M
Harmon Cyrus
5 Sep 2023
Director
Sold on a plan
10,000
$11.62
$116.20K
Harmon Cyrus
31 Aug 2023
Director
Sold on a plan
15,000
$9.36
$140.40K
Harmon Cyrus
16 Aug 2023
Director
Sold on a plan
15,000
$10.14
$152.10K
Harmon Cyrus
8 Jun 2023
Director
Sell
10,000
$6.30
$63.00K
Harmon Cyrus
6 Jun 2023
Director
Sell
5,000
$6.30
$31.48K
Harmon Cyrus
5 Jun 2023
Director
Sell
5,000
$6.05
$30.23K
Kovacs Shane William Charles
6 Apr 2023
CH. OPERATING & FINANCIAL OFF.
Buy
10,000
—
no price
Kovacs Shane William Charles
2 Sep 2022
CH. OPERATING & FINANCIAL OFF.
Buy
20,000
—
no price
BVF PARTNERS L P/IL
10 Jun 2022
Director
Buy
41,417
$4.03
$167.10K
BVF PARTNERS L P/IL
10 Jun 2022
Director
Buy
158,583
$4.03
$639.80K
Horn Kinney
10 Mar 2022
CHIEF BUSINESS OFFICER
Sold after exercise
5,253
$4.75
$24.95K
Horn Kinney
10 Feb 2022
CHIEF BUSINESS OFFICER
Exercised, kept
5,251
$2.06
$10.84K
Horn Kinney
10 Jan 2022
CHIEF BUSINESS OFFICER
Sold after exercise
5,251
$6.85
$35.97K
Myles David C.
10 Dec 2021
CHIEF DEVELOPMENT OFFICER
Sell
10,000
$10.30
$103.00K
Horn Kinney
10 Dec 2021
CHIEF BUSINESS OFFICER
Sold after exercise
5,251
$10.39
$54.56K
BVF PARTNERS L P/IL
30 Nov 2021
Director
Buy
35,268
$9.39
$331.18K
BVF PARTNERS L P/IL
30 Nov 2021
Director
Buy
341,977
$9.39
$3.21M
BVF PARTNERS L P/IL
30 Nov 2021
Director
Buy
362,430
$9.39
$3.40M
Harmon Cyrus
29 Nov 2021
CHIEF TECHNOLOGY OFFICER
Sell
400
$24.76
$9.90K
Horn Kinney
10 Nov 2021
CHIEF BUSINESS OFFICER
Sold after exercise
27,668
$26.88
$743.72K
Harmon Cyrus
19 Oct 2021
CHIEF TECHNOLOGY OFFICER
Sell
4,555
$28.20
$128.45K
Harmon Cyrus
19 Oct 2021
CHIEF TECHNOLOGY OFFICER
Sell
7,445
$27.85
$207.34K
Bohen Sean
14 Oct 2021
PRESIDENT AND CEO
Sold after exercise
351
$31.17
$10.94K
Bohen Sean
14 Oct 2021
PRESIDENT AND CEO
Sold after exercise
4,649
$30.42
$141.42K
Horn Kinney
11 Oct 2021
CHIEF BUSINESS OFFICER
Sold after exercise
3,146
$28.19
$88.69K
Horn Kinney
11 Oct 2021
CHIEF BUSINESS OFFICER
Sold after exercise
2,105
$27.47
$57.82K
Bohen Sean
27 Sep 2021
PRESIDENT AND CEO
Sold after exercise
1,085
$30.07
$32.63K
Harmon Cyrus
20 Sep 2021
CHIEF TECHNOLOGY OFFICER
Sell
12,000
$26.30
$315.60K
Horn Kinney
10 Sep 2021
CHIEF BUSINESS OFFICER
Sold after exercise
5,251
$29.38
$154.27K
Bohen Sean
8 Sep 2021
PRESIDENT AND CEO
Sold after exercise
2,631
$30.00
$78.93K
Bohen Sean
7 Sep 2021
PRESIDENT AND CEO
Sold after exercise
413
$30.08
$12.42K
Bohen Sean
1 Sep 2021
PRESIDENT AND CEO
Sold after exercise
871
$30.05
$26.17K
Harmon Cyrus
19 Aug 2021
CHIEF TECHNOLOGY OFFICER
Sell
12,000
$24.97
$299.64K
Horn Kinney
10 Aug 2021
CHIEF BUSINESS OFFICER
Sold after exercise
60
$26.17
$1.57K
Horn Kinney
10 Aug 2021
CHIEF BUSINESS OFFICER
Sold after exercise
5,191
$25.70
$133.41K
Harmon Cyrus
20 Jul 2021
CHIEF TECHNOLOGY OFFICER
Sell
4,123
$25.63
$105.67K
Harmon Cyrus
19 Jul 2021
CHIEF TECHNOLOGY OFFICER
Sell
7,877
$24.83
$195.59K
Horn Kinney
12 Jul 2021
CHIEF BUSINESS OFFICER
Sold after exercise
1,392
$27.00
$37.58K
Horn Kinney
12 Jul 2021
CHIEF BUSINESS OFFICER
Sold after exercise
3,859
$26.33
$101.61K
Harmon Cyrus
18 Jun 2021
CHIEF TECHNOLOGY OFFICER
Sell
600
$26.30
$15.78K
Harmon Cyrus
18 Jun 2021
CHIEF TECHNOLOGY OFFICER
Sell
1,990
$25.59
$50.92K
Harmon Cyrus
18 Jun 2021
CHIEF TECHNOLOGY OFFICER
Sell
9,410
$24.54
$230.92K
Horn Kinney
10 Jun 2021
CHIEF BUSINESS OFFICER
Sold after exercise
2,787
$29.97
$83.53K
Horn Kinney
10 Jun 2021
CHIEF BUSINESS OFFICER
Sold after exercise
2,164
$29.60
$64.05K
Horn Kinney
10 Jun 2021
CHIEF BUSINESS OFFICER
Sold after exercise
300
$28.30
$8.49K
Horn Kinney
18 May 2021
CHIEF BUSINESS OFFICER
Sold after exercise
8,621
$24.81
$213.89K
Horn Kinney
18 May 2021
CHIEF BUSINESS OFFICER
Sold after exercise
49,142
$24.03
$1.18M
Graham G. Walmsley
23 Nov 2020
Director
Buy
indirect
1,160,000
$19.00
$22.04M
Cormorant Asset Management, LP
23 Nov 2020
Former 10% Owner
Buy
indirect
425,000
$19.00
$8.08M
BVF PARTNERS L P/IL
19 Nov 2020
Director
Buy
74,991
$19.00
$1.42M
BVF PARTNERS L P/IL
19 Nov 2020
Director
Buy
446,425
$19.00
$8.48M
BVF PARTNERS L P/IL
19 Nov 2020
Director
Buy
613,918
$19.00
$11.66M
Bohen Sean
23 Sep 2020
President and CEO
Exercised, kept
51,649
$4.82
$249.15K
BUTITTA CYNTHIA M
16 Sep 2020
Director
Exercised, kept
83,876
$4.41
$369.56K
